| Range | Low Price | High Price |
|---|---|---|
| 30 days | $1.43 | $1.43 |
| 90 days | $1.43 | $1.43 |
| 52 weeks | $1.27 | $2.92 |
Is OrganiGram a good stock to buy?
OrganiGram has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.
Should I sell OrganiGram stock?
OrganiGram Holdings Inc. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Will OrganiGram go up?
The 11 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.36, with a high estimate of 2.90 and a low estimate of 1.78. The median estimate represents a +118.71% increase from the last price of 1.08.
Is OrganiGram a good long term investment?
Organigram's Low Product Costs and Solid Capacity But interestingly, it appears to be performing much better overall. Its annual production rate lies around 62,000 kilograms, and by fall this year, the company's total capacity is expected to be at 113,000 kilograms.
Is OrganiGram a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
What is happening with OrganiGram?
OrganiGram (OGI) Reports Q3 Loss, Tops Revenue Estimates OrganiGram (OGI) delivered earnings and revenue surprises of -50% and 5.67%, respectively, for the quarter ended May 2022.
Will Tilray go up?
Tilray Brands Inc (NASDAQ:TLRY) The 16 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 5.25, with a high estimate of 23.00 and a low estimate of 2.60. The median estimate represents a +54.87% increase from the last price of 3.39.
Is OHI stock a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
What is going on with OrganiGram?
OrganiGram (OGI) Reports Q2 Loss, Tops Revenue Estimates OrganiGram (OGI) delivered earnings and revenue surprises of 0% and 3.15%, respectively, for the quarter ended February 2022.
Is Sundial growers a good stock to buy?
Sundial Growers is a strong company with good prospects for continued growth. But, its stock price has been incredibly low the past year or so. Sundial is a good company to invest in for the long-term.
Who invested in OrganiGram?
Who invested in OrganiGram ? OrganiGram has 2 investors including British American Tobacco and Bank of Montreal .
Signals & Forecast
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, January 27, 2022, and so far it has risen 6.87%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Is OrganiGram Holdings stock A Buy?
OrganiGram Holdings finds support from accumulated volume at $1.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Golden Star Signal
OrganiGram Holdings holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
OGRMF Stock
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
OrganiGram Q1 2019 Financial Report
I’ve made no secret that one of my favorite marijuana penny stocks, OrganiGram Holdings Inc (OTCMKTS:OGRMF, CVE:OGI), still has a ton of room left to grow. OrganiGram stock easily has the potential to gain 100% by year’s end.
Analyst Take
OrganiGram’s net sales for the last quarter hit CA$12.4 million, up from CA$2.4 million in the same prior-year period and up from CA$3.2 million in Q4 2018. That represents 419% and 287% jumps, respectively.
Orogen Receives First Royalty Payment from the Ermitaño Deposit
When it comes to top pot stocks, there’s no shortage of competitive choices. But when it comes to the stocks that have the biggest potential to see huge gains fast, I believe that OrganiGram stock has the highest ceiling.
Orogen Sells Onjo to Pacific Ridge for Cash, Shares and a Royalty
Ongoing exploration indicates new discovery east of ErmitañoVANCOUVER, BC / ACCESSWIRE / February 16, 2022 / (TSXV:OGN) (OTCQX:OGNRF) Orogen Royalties Inc.
Orogen Retains CEO for Ball Creek Spinout
VANCOUVER, BC / ACCESSWIRE / February 3, 2022 / (TSXV:OGN) (OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that it has signed a purchase and sale agreement (the "Agreement") with Pacific Ridge Exploration Ltd.
